Blood Test Measuring CtDNA Predicts DLBCL Treatment Response, Study Suggests.
August 27, 2018
MedPage Today (8/25, Bassett) reported that “a blood test that measures the levels of circulating tumor DNA (ctDNA) successfully predicted how likely patients with diffuse large B-cell lymphoma (DLBCL) were to respond to initial therapy,” according to a...